The predictive value of PET-CT and PET-DW-MRI early during chemoradiotherapy for locoregional control of advanced stage head and neck cancer

The predictive value of PET-CT and PET-DW-MRI early during chemoradiotherapy for locoregional control of advanced stage head and neck cancer - PREDICTION study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON41220

Enrollment

Registered

2013-07-10

Start date

2013-10-17

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

head and neck cancer head and neck squamous cell carcinoma

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: patients with resectable advanced (stage III and IV) HNSCC scheduled for primary non-surgical treatment (chemoradiotherapy) with curative intent.

Exclusion criteria

Exclusion criteria: technically inoperable tumor every condition making MRI imposssible

Design outcomes

Primary

Measure	Time frame
Criteria for predicting locoregional response and accuracy of FDG-PET-CT and DW-MRI (EPI and non-EPI technique).	—

Secondary

Measure	Time frame
Feasibility of PET-MRI.	—

Countries

Netherlands

Outcome results